Celularity Financial Statements From 2010 to 2025

CELU Stock  USD 1.54  0.05  3.36%   
Celularity financial statements provide useful quarterly and yearly information to potential Celularity investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Celularity financial statements helps investors assess Celularity's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Celularity's valuation are summarized below:
Gross Profit
30.9 M
Profit Margin
(0.73)
Market Capitalization
35.5 M
Enterprise Value Revenue
2.166
Revenue
48.2 M
There are currently one hundred twenty fundamental signals for Celularity that can be evaluated and compared over time across rivals. All traders should validate Celularity's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 48.1 M in 2025. Enterprise Value is likely to drop to about 119.3 M in 2025

Celularity Total Revenue

22.05 Million

Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Net Income Applicable To Common Shares of 17.1 M or Income Tax Expense of 12.1 K, as well as many indicators such as Price To Sales Ratio of 2.11, Dividend Yield of 0.0 or PTB Ratio of 1.02. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Celularity Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets286.9 M165.5 M133.5 M
Slightly volatile
Short and Long Term Debt Total40.5 M75.2 M21.1 M
Slightly volatile
Total Current Liabilities39.3 M77.4 M18.8 M
Slightly volatile
Other Liabilities95.8 M100.9 M269.2 M
Slightly volatile
Accounts Payable9.1 M16.3 M6.9 M
Slightly volatile
Cash194.1 K204.3 K6.7 M
Slightly volatile
Non Current Assets Total258.1 M142.7 M120 M
Slightly volatile
Other Assets16.9 M20.6 M10.3 M
Slightly volatile
Cash And Short Term Investments248 K261.1 K6.7 M
Slightly volatile
Net Receivables7.5 M12.1 M5.4 M
Slightly volatile
Common Stock Total Equity201.1 M313.9 M117.6 M
Slightly volatile
Liabilities And Stockholders Equity308.3 M165.5 M134.8 M
Slightly volatile
Inventory5.8 M6.6 M4.5 M
Slightly volatile
Other Current Assets2.7 M1.7 M1.3 M
Slightly volatile
Other Stockholder Equity510 MB269.2 M
Slightly volatile
Total Liabilities88 M92.6 M112 M
Slightly volatile
Total Current Assets28.8 M22.8 M13.5 M
Slightly volatile
Common Stock16.2 K17.1 K16.2 M
Very volatile
Property Plant Equipment69.1 M104.2 M39.9 M
Slightly volatile
Property Plant And Equipment Net90.5 M90.6 M74.6 M
Slightly volatile
Warrants193.9 M188.2 M248.4 M
Slightly volatile
Good Will6.3 M6.6 M103.6 M
Slightly volatile
Common Stock Shares Outstanding13.1 M17.8 M7.2 M
Slightly volatile
Non Current Liabilities Total30.5 M32.1 M108.9 M
Pretty Stable
Capital Surpluse28 M55.6 M18.9 M
Slightly volatile
Non Current Liabilities Other2.1 M2.2 M33 M
Slightly volatile
Intangible Assets9.4 M9.9 M194.7 M
Slightly volatile
Current Deferred Revenue2.4 M2.6 M4.1 M
Slightly volatile
Capital Lease Obligations23.2 M23.6 M29.3 M
Slightly volatile
Deferred Long Term Liabilities482542591
Slightly volatile
Property Plant And Equipment Gross114.9 M122 M101.6 M
Slightly volatile
Capital Stock12.9 K21.9 K5.7 K
Slightly volatile
Short Term Debt22.8 M45.1 M11.3 M
Slightly volatile
Short and Long Term Debt42.3 M45.1 M38.5 M
Slightly volatile

Celularity Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization7.3 M10.7 M6.7 M
Slightly volatile
Selling General Administrative49.4 M50.5 M20.2 M
Slightly volatile
Selling And Marketing Expenses37.6 K39.6 K805 K
Slightly volatile
Total Revenue22.1 M26.2 M21 M
Very volatile
Other Operating Expenses141.8 M247.3 M65.6 M
Slightly volatile
Research Development43.5 M27.4 M48.8 M
Very volatile
Cost Of Revenue13.3 M18.4 M9.1 M
Slightly volatile
Total Operating Expenses127.2 M199 M52.3 M
Slightly volatile
Interest Income277.4 K288 K353.3 K
Slightly volatile
Reconciled Depreciation9.8 M10.7 M8.6 M
Slightly volatile

Celularity Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation8.8 M10.7 M6.5 M
Slightly volatile
Capital Expenditures3.5 M3.6 M6.2 M
Pretty Stable
Total Cash From Financing Activities20.6 M21.7 M85.8 M
Very volatile
End Period Cash Flow11.1 M11.7 M11.5 M
Slightly volatile
Stock Based Compensation17.2 M17.3 M9.2 M
Slightly volatile
Begin Period Cash Flow40.8 M33.1 M16.8 M
Slightly volatile
Issuance Of Capital Stock18.7 M19.7 M81.8 M
Slightly volatile
Dividends Paid31.3 M35.2 M38.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.112.22121
Slightly volatile
Days Sales Outstanding108175111
Slightly volatile
Average Payables2.1 M2.4 M2.6 M
Slightly volatile
Stock Based Compensation To Revenue0.550.590.459
Slightly volatile
Capex To Depreciation0.470.50.9235
Pretty Stable
EV To Sales5.245.51122
Slightly volatile
Inventory Turnover1.682.511.9757
Slightly volatile
Days Of Inventory On Hand231151201
Very volatile
Payables Turnover1.241.322.1945
Very volatile
Sales General And Administrative To Revenue1.822.00.9652
Slightly volatile
Research And Ddevelopement To Revenue2.311.22.1324
Slightly volatile
Capex To Revenue0.190.20.3485
Pretty Stable
Cash Per Share0.01390.01470.6388
Pretty Stable
Days Payables Outstanding197290269
Pretty Stable
Intangibles To Total Assets0.140.1511.9 K
Slightly volatile
Current Ratio0.320.340.7188
Pretty Stable
Receivables Turnover3.342.163.6693
Slightly volatile
Capex Per Share0.250.261.144
Pretty Stable
Revenue Per Share2.761.471.4482
Slightly volatile
Interest Debt Per Share4.794.422.2094
Slightly volatile
Debt To Assets0.50.523.5326
Slightly volatile
Graham Number17.4618.3855.1022
Slightly volatile
Operating Cycle258293294
Pretty Stable
Days Of Payables Outstanding197290269
Pretty Stable
Net Income Per E B T0.780.90.9148
Pretty Stable
Cash Ratio0.00370.00390.5732
Pretty Stable
Days Of Inventory Outstanding231151201
Very volatile
Days Of Sales Outstanding108175111
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.211.27K
Slightly volatile
Fixed Asset Turnover0.320.332.5776
Slightly volatile
Debt Ratio0.50.523.5326
Slightly volatile
Price Sales Ratio2.112.22121
Slightly volatile
Asset Turnover0.170.18400
Slightly volatile

Celularity Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap48.1 M50.6 M249.8 M
Pretty Stable
Enterprise Value119.3 M125.6 M282.4 M
Very volatile

Celularity Fundamental Market Drivers

Cash And Short Term Investments227 K

Celularity Upcoming Events

2nd of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Celularity Financial Statements

Celularity shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.6 M2.4 M
Total Revenue26.2 M22.1 M
Cost Of Revenue18.4 M13.3 M
Stock Based Compensation To Revenue 0.59  0.55 
Sales General And Administrative To Revenue 2.00  1.82 
Research And Ddevelopement To Revenue 1.20  2.31 
Capex To Revenue 0.20  0.19 
Revenue Per Share 1.47  2.76 
Ebit Per Revenue(9.71)(9.23)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.